A combo trial? That's kind of interesting. Tie your line to a big pharma and see what happens. You might get carried away like a mouse tied to a hot air balloon.
Yep, I saw your last post about that. I would take the offer. Otherwise NP would be challenging the status quo on big pharma. This is his “in”. If he refuses I doubt they let him run on his own. But eventually the data will show leronlimab is the heavyweight in this battle.
News 
Market Data 
Discover 
